Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$54.67M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	3.42M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,107,314
Open	16.01
Previous Close	15.76
Day's Range	15.35 - 16.14
52-Week Low	9.60
52-Week High	26.17
Beta	n/a
Holdings	11
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

265.05% of assets

Name	Symbol	Weight
LLY SWAP NOMURA	n/a	68.63%
ELI LILLY & CO SWAP CS	n/a	44.37%
ELI LILLY & CO SWAP Cantor - L	n/a	41.92%
ELI LILLY & CO SWAP MAREX	n/a	39.56%
US DOLLARS	n/a	29.61%
DEPOSITS WITH BROKER FOR SHORT POSITIONS	n/a	19.47%
United States Treasury Bills 0%	B.0 10.28.25	12.80%
ELI LILLY & CO SWAP MS	n/a	5.29%
United States Treasury Bills 0%	B.0 11.20.25	3.38%
First American Government Obligations Fund	FGXXX	0.02%

Performance

LLYX had a total return of -39.06% in the past year, including dividends. Since the fund's inception, the average annual return has been -29.02%.